Stay updated with breaking news from Abivax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
13.03.2023 - EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax does not hold any cash or otherwise have any deposits at SVB or at any other U.S. financial institution 13.03.2023 / 12:00 CET/CEST The issuer is solely responsible for the content of this ...
EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax publishes a prospectus in the context of its capital increase 23.02.2023 / 20:00 CET/CEST The issuer is solely responsible for the content of this announcement. Abivax publishes a prospectus in the context of its capital increase PARIS, FRANCE...
EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax publishes a prospectus in the context of its capital increase 23.02.2023 / 20:00 CET/CEST The issuer is solely responsible for
PARIS, FRANCE / ACCESSWIRE / February 23, 2023 / Abivax (Euronext Paris: FR0012333284 - ABVX) (the "Company"), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR TO U.S. PERSONSAbivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US